JNCCN-360

Advertisement

Advertisement

A Patient’s Story: NCCN Guidelines for Patients® Helped Me Ask The Right Questions

Crystal S. Denlinger, MD, and Ann H. Partridge, MD, MPH, on Making Sense of Guidelines and Guidance

A Patient’s Story: How NCCN Guidelines for Patients® Helped Me and My Caregiver

Recent

NCCN Annual Conference 2018: Debut of New Guidelines on Immunotherapy-Related Toxicity

ELCC 2018: Patient-Reported Outcomes With Alectinib Versus Crizotinib in ALK-Positive Lung Cancer

AACR 2018: First-Line Pembrolizumab Plus Chemotherapy for Metastatic Lung Cancer

ELCC 2018: Updated Survival Results With Atezolizumab in the POPLAR Trial

In the

Medical Literature

Predictor of Response Rates to Anti–PD-1 Therapies Across Cancer Types

Long-Term Survival With Nivolumab in Pretreated Patients With Advanced Lung Cancer

Update on Genomic Testing for Patients With Lung Cancer

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer

Active

Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial

Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers

Treatment of EGFR-Mutated NSCLC: Assessing Your Clinical Practice

The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer

Available

Clinical Trials

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

University Hospitals Seidman Cancer Center

Huntsman Cancer Institute at the University of Utah

University of Wisconsin Carbone Cancer Center

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved